0001209191-22-016629.txt : 20220307
0001209191-22-016629.hdr.sgml : 20220307
20220307161427
ACCESSION NUMBER: 0001209191-22-016629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20220307
DATE AS OF CHANGE: 20220307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scimeca Dario
CENTRAL INDEX KEY: 0001779581
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 22718155
MAIL ADDRESS:
STREET 1: C/O PRECISION BIOSCIENCES, INC.
STREET 2: 302 E. PETTIGREW STREET, SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-28
0
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001779581
Scimeca Dario
C/O PRECISION BIOSCIENCES, INC.
302 E PETTIGREW STREET, SUITE A-100
DURHAM
NC
27701
0
1
0
0
General Counsel and Secretary
Common Stock
2020-02-28
5
A
0
E
2072
5.61
A
2072
D
Common Stock
2020-08-31
5
A
0
E
3156
4.79
A
5228
D
Common Stock
2021-02-26
5
A
0
E
2748
4.61
A
7976
D
Common Stock
2021-08-31
5
A
0
E
548
10.68
A
8524
D
Common Stock
2022-02-28
5
A
0
E
2049
3.61
A
10573
D
Employee Stock Option (Right to Buy)
4.08
2022-03-03
4
A
0
131271
0.00
A
2032-03-02
Common Stock
131271
131271
D
Restricted Stock Units
2022-03-03
4
A
0
82659
0.00
A
Common Stock
82659
82659
D
The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of
each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through
the applicable vesting dates.
The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the
Company's Common Stock.
The RSUs shall vest in three equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
/s/ Dario Scimeca
2022-03-07